Gapping down
In reaction to earnings/guidance:
- NIU -2.6%
Other news:
- LTCH -4.1% (completes workforce reduction)
- VIR -2.7% (terminates collaboration agreement with WuXi Bio; other existing agreements between co and WuXi Bio remain in effect)
- CABO -1.8% (authorizes additional repurchases of up to $450 million of Cable One's common stock)
- OCGN -1.3% (FDA removes clinical hold on phase 2/3 clinical trial for COVAXIN)
Analyst comments:
- ADSK -3.4% (downgraded to Hold from Buy at Deutsche Bank)
- GLW -2.9% (downgraded to Neutral from Buy at Citigroup)
- HPQ -2.8% (downgraded to Neutral from Buy at Citigroup)
- PTVE -1.6% (downgraded to Neutral from Buy at Citigroup)
- SKLZ -1.6% (downgraded to Neutral from Buy at Citigroup)
- DOW -0.8% (downgraded to Neutral from Overweight at Piper Sandler)